Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000168959 | SCV000305596 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001618321 | SCV001159569 | benign | not provided | 2023-03-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001618321 | SCV001846590 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002054014 | SCV002434425 | benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002054014 | SCV002805652 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2022-02-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445600 | SCV004173866 | benign | Dilated cardiomyopathy 1D | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445601 | SCV004173867 | benign | Cardiomyopathy, familial restrictive, 3 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445599 | SCV004173868 | benign | Hypertrophic cardiomyopathy 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000168959 | SCV001924237 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000168959 | SCV001951942 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000168959 | SCV001976278 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV003126564 | SCV003803647 | benign | Hypertrophic cardiomyopathy | 2022-09-27 | no assertion criteria provided | clinical testing |